Table: Pharmarise Holdings -2015/16 group results

Pharmarise Holdings

13/07/2016 09:00

Jul 13 (Reuters)-  
          Pharmarise Holdings Corp  
          CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified) 
                   Year ended      Year ended       Year to        NEXT      
                May 31, 2016    May 31, 2015   May 31, 2017      YEAR        
                   LATEST         YEAR-AGO        COMPANY        COMPANY     
                   RESULTS         RESULTS       FORECAST      H1 FORECAST   
  Sales             48.51           39.51          52.00          25.50      
                 (+22.8 pct)     (+3.4 pct)     (+7.2 pct)     (+19.4 pct)   
  Operating        813 mln           1.14         810 mln        195 mln     
                 (-28.9 pct)     (-27.3 pct)    (-0.4 pct)     (-61.0 pct)   
  Recurring        659 mln         997 mln        640 mln        120 mln     
                 (-33.9 pct)     (-21.6 pct)    (-3.0 pct)     (-71.6 pct)   
  Net 
  Net              382 mln         227 mln        100 mln     loss 140 mln   
                 (+67.7 pct)     (-38.3 pct)    (-73.8 pct)                  
  EPS             42.44 yen       25.31 yen      11.10 yen   loss 15.54 yen  
  EPS Diluted     41.55 yen       24.99 yen                                  
  Ann Div         14.00 yen       16.00 yen      14.00 yen                   
  -Q2 Div            NIL             NIL            NIL                      
  -Q4 Div         14.00 yen       16.00 yen      14.00 yen                   
   
  NOTE - Pharmarise Holdings Corp. 
  *Second Net profit row denotes profit attributable to owners ofthe parent  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2796.T 
  ((Tokyo Headline News Desk +813 6441 1812))